Application no. and date | 05810288.0 (espacenet) (Federated) (European Patent Register), 20050915 | Patent/reg. no. and date | DK/EP 1809273, 20100414 | Publication date | 20070725 | Priority no. and date | US 610276 P, 20040916, US 698625 P, 20050712, US 707242 P, 20050811 | EP pub. no. and date |
EP 1809273 20070725 | Effective date | | Applicant/owner | JANSSEN PHARMACEUTICA N.V., Turnhoutseweg 30
2340 Beerse, BE | Applicant ref. no. | 138471 | Inventor | ZHAO, Boyu, 105 Weymouth Circle
Lansdale, Pennsylvania 19446, US, CHOI, Yong Moon, 101 Windsor Drive
Pine Brook, New Jersey 07058, US, GORDON, Robert, 2 Hobbs Court
Robbinsville, New Jersey 08691, US, NOVAK, Gerald P., 17 Concord Lane
Skillman, New Jersey 08558, US, PLATA-SALAMAN, Carlos R., 870 SugarBush Ridge
Zionsville, Indiana 46077, US, TWYMAN, Roy E, 3355 Byron Drive
Doylestown, Pennsylvania 18901, US, WHITE, H. Steve, 3734 East Viewcrest Circle
Salt Lake City, Utah 84124, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/27 (2006.01) , A61P 25/08 (2006.01) | Title | Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese | Int. application no. | US2005032861 | Int. publication no. | WO2006033947 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|